Уравнение обострения ХОБЛ: что мы знаем о переменных? Обзор литературы
Аннотация. В обзоре обобщаются данные, посвященные проблеме обострений хронической обструктивной болезни легких (ХОБЛ). Рассматриваются последствия обострений на прогрессирование заболевания и риски возникновения осложнений со стороны других органов и систем. Приводятся современные данные о роли различных микроорганизмов в возникновении обострений ХОБЛ. Актуализируется информация о влиянии фактора недостаточного питания на характеристики течения ХОБЛ у пациентов и возможности его коррекции. Обозначены нерешенные вопросы и важность дальнейших исследований в указанном направлении.Д.Ю. Костенко
Ключевые слова
хроническая обструктивная болезнь легких
обострение хронической обструктивной болезни легких
респираторные инфекции
недостаточность питания
Список литературы
1. Клинические рекомендации. Хроническая обструктивная болезнь легких. Российское респираторное общество. Рубрикатор клинических рекомендаций Минздрава России. 2021. ID: 603. Доступ: https://cr.minzdrav.gov.ru/schema/603_2 (дата обращения – 01.09.2023).
2. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Revised 2022. URL: https://goldcopd.org/archived-reports/ (date of access – 01.09.2023).
3. Авдеев С.Н. Хроническая обструктивная болезнь легких: обострения. Пульмонология. 2013; (3): 5–19.
4. Donaldson G.C., Hurst J.R., Smith C.J. et al. Increased risk of myocardial infarction and stroke following exacerbation of COPD. Chest. 2010; 137(5): 1091–97. https://dx.doi.org/10.1378/chest.09-2029.
5. Dransfield M.T., Kunisaki K.M., Strand M.J. et al.; COPDGene Investigators. Acute exacerbations and lung function loss in smokers with and without chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2017; 195(3): 324–30. https://dx.doi.org/10.1164/rccm.201605-1014OC.
6. Suissa S., Dell’aniello S., Ernst P. Long-term natural history of chronic obstructive pulmonary disease: Severe exacerbations and mortality. Thorax. 2012; 67(11): 957–63. https://dx.doi.org/10.1136/thoraxjnl-2011-201518.
7. Hill A.T., Campbell E.J., Hill S.L. et al. Association between airway bacterial load and markers of airway inflammation in patients with stable chronic bronchitis. Am J Med. 2000; 109(4): 288–95. https://dx.doi.org/10.1016/S0002-9343(00)00507-6.
8. Patel I.S., Seemungal T.A.R., Wilks M. et al. Relationship between bacterial colonization and the frequency, character and severity of COPD exacerbations. Thorax. 2002; 57(9): 759–64. https://dx.doi.org/10.1136/thorax.57.9.759.
9. Wang Z., Maschera B., Lea S. et al. Airway-host microbiome interactions in chronic obstructive pulmonary disease. Respir Res. 2019; 20(1): 113. https://dx.doi.org/10.1186/s12931-019-1085-z.
10. Singh R., Mackay A.J., Patel A.R.C. et al. Inflammatory thresholds and the species-specific effects of colonizing bacteria in stable chronic obstructive pulmonary disease. Respir Res. 2014; 15(1): 114. https://dx.doi.org/10.1186/s12931-014-0114-1.
11. Wang Z., Singh R., Miller B.E. et al. Sputum microbiome temporal variability and dysbiosis in chronic obstructive pulmonary disease exacerbations: An analysis of the COPDMAP study. Thorax. 2018; 73(4): 331–38. https://dx.doi.org/10.1136/thoraxjnl-2017-210741.
12. Miravitlles M., Marin A., Monso E. et al. Efficacy of moxifloxacin in the treatment of bronchial colonization in COPD. Eur Respir J. 2009; 34(5): 1066–71. https://dx.doi.org/10.1183/09031936.00195608.
13. Cameron R.J., de Wit D., Welsh T.N. et al. Virus infection in exacerbations of chronic obstructive pulmonary disease requiring ventilation. Intensive Care Med. 2006; 32(7): 1022–29. https://dx.doi.org/10.1007/s00134-006-0202-x.
14. Bouquet J., Tabor D.E., Silver J.S. et al. Microbial burden and viral exacerbations in a longitudinal multicenter COPD cohort. Respir Res. 2020; 21(1): 77. https://dx.doi.org/10.1186/s12931-020-01340-0.
15. McManus T.E., Marley A.-M., Baxter N. et al. Respiratory viral infection in exacerbations of COPD. Respir Med. 2008; 102(11): 1575–80. https://dx.doi.org/10.1016/j.rmed.2008.06.006.
16. Mallia P., Message S.D., Gielen V. et al. Experimental rhinovirus infection as a human model of chronic obstructive pulmonary disease exacerbation. Am J Respir Crit Care Med. 2011; 183(6): 734–42. https://dx.doi.org/10.1164/rccm.201006-0833OC.
17. Beekat-Berkani R., Wilkinson T., Buchy P. et al. Seasonal influenza vaccination in patients with COPD: A systematic literature review. BMC Pulm Med. 2017; 17(1): 79. https://dx.doi.org/10.1186/s12890-017-0420-8.
18. Modestou M.A., Manzel L.J., El-Mahdy S. et al. Inhibition of IFN-γ-dependent antiviral airway epithelial defense by cigarette smoke. Respir Res. 2010; 11(1): 64. https://dx.doi.org/10.1186/1465-9921-11-64.
19. Groskreutz D.J., Monick M.M., Babor E.C. et al. Cigarette smoke alters respiratory syncytial virus-induced apoptosis and replication. Am J Respir Cell Mol. Biol. 2009; 41(2): 189–98. https://dx.doi.org/10.1165/rcmb.2008-0131OC.
20. Государственный реестр лекарственных средств Минздрава России. Доступ: https://grls.rosminzdrav.ru/ (дата обращения – 01.09.2023).
21. Радченко Е.В., Суховская О.А., Галанкин Т.Л. с соавт. Сетевой метаанализ: сравнение эффективности и безопасности частичных агонистов никотиновых ацетилхолиновых рецепторов варениклина и цитизина для лечения никотиновой зависимости. Обзоры по клинической фармакологии и лекарственной терапии. 2018; 16(4): 19–32.
22. Papi A., Bellettato C.M., Braccioni F. et al. Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations. Am J Respir Crit Care Med. 2006; 173(10): 1114–21. https://dx.doi.org/10.1164/rccm.200506-859OC.
23. Mallia P., Footitt J., Sotero R. et al. Rhinovirus infection induces degradation of antimicrobial peptides and secondary bacterial infection in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2012; 186(11): 1117–24. https://dx.doi.org/10.1164/rccm.201205-0806OC.
24. Tong X., Cheng A., Xu H. et al. Aspergillus fumigatus during COPD exacerbation: A pair-matched retrospective study. BMC Pulm Med. 2018; 18(1): 55. https://dx.doi.org/10.1186/s12890-018-0611-y.
25. Huerta A., Soler N., Esperatti M. et al. Importance of Aspergillus spp. isolation in acute exacerbations of severe COPD: Prevalence, factors and follow-up: The FUNGI-COPD study. Respir Res. 2014; 15(1): 17. https://dx.doi.org/10.1186/1465-9921-15-17.
26. Wu Y.X., Zuo Y.H., Cheng Q.J. et al. Respiratory Aspergillus colonization was associated with relapse of acute exacerbation in patients with chronic obstructive pulmonary disease: Analysis of data from a retrospective cohort study. Front Med (Lausanne). 2021; 8: 640289. https://dx.doi.org/10.3389/fmed.2021.640289.
27. Taccone F.S., Van den Abeele A., Bulpa P. et al. Epidemiology of invasive aspergillosis in critically ill patients: Clinical presentation, underlying conditions, and outcomes. Crit Care. 2015; 19(1): 7. https://dx.doi.org/10.1186/s13054-014-0722-7.
28. Guinea J., Torres-Narbona M., Gijon P. et al. Pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: Incidence, risk factors, and outcome. Clin Microbiol Infect. 2010; 16(7): 870–77. https://dx.doi.org/10.1111/j.1469-0691.2009.03015.x.
29. Xue T., Ma Z., Liu F. et al. Pneumocystis jirovecii colonization and its association with pulmonary diseases: A multicenter study based on a modified loop-mediated isothermal amplification assay. BMC Pulm Med. 2020; 20(1): 70. https://dx.doi.org/10.1186/s12890-020-1111-4.
30. Canas-Arboleda A., Hernandez-Florez C., Garzon J. et al. Colonization by Pneumocystis jirovecii in patients with chronic obstructive pulmonary disease: Association with exacerbations and lung function status. Braz J Infect Dis. 2019; 23(5): 352–57. https://dx.doi.org/10.1016/j.bjid.2019.08.008.
31. Костенко Д.Ю., Зайкова-Хелимская И.В. Влияние пневмоцистной инфекции на клинические проявления хронической обструктивной болезни легких. Дальневосточный медицинский журнал. 2020; (3): 90–95.
32. Костенко Д.Ю., Зайкова-Хелимская И.В. Оценка влияния и коррекции пневмоцистной инфекции на клинико-лабораторные характеристики хронической обструктивной болезни легких. Бюллетень физиологии и патологии дыхания. 2020; (78): 23–30.
33. Драпкина О.М., Авдеев С.Н., Будневский А.В. с соавт. Пищевой статус и парадокс ожирения при хронической обструктивной болезни легких. Вопросы питания. 2021; 90(6): 42–49.
34. Katsura H., Yamada K., Kida K. Both generic and disease specific health related quality of life are deteriorated in patients with underweight COPD. Respir Med. 2005; 99(5): 624–30. https://dx.doi.org/10.1016/j.rmed.2004.09.017.
35. Marco E., Sanchez-Rodriguez D., Davalos-Yerovi V.N. et al. Malnutrition according to ESPEN consensus predicts hospitalizations and long-term mortality in rehabilitation patients with stable chronic obstructive pulmonary disease. Clin Nutr. 2019; 38(5): 2180–86. https://dx.doi.org/10.1016/j.clnu.2018.09.014.
36. Yazdanpanah L., Shidfar F., Moosavi A.J. et al. Energy and protein intake and its relationship with pulmonary function in chronic obstructive pulmonary disease (COPD) patients. Acta Med Iran. 2010; 48(6): 374–79.
37. Luo Y., Zhou L., Li Y. et al. Fat-free mass index for evaluating the nutritional status and disease severity in COPD. Respir Care. 2016; 61(5): 680–88. https://dx.doi.org/10.4187/respcare.04358.
38. Hallin R., Koivisto-Hursti U.K., Lindberg E. et al. Nutritional status, dietary energy intake and the risk of exacerbations in patients with chronic obstructive pulmonary disease (COPD). Respir Med. 2006 Mar; 100(3): 561–67. https://dx.doi.org/10.1016/j.rmed.2005.05.020.
39. Hoong J.M., Ferguson M., Hukins C. et al. Economic and operational burden associated with malnutrition in chronic obstructive pulmonary disease. Clin Nutr. 2017; 36(4): 1105–9. https://dx.doi.org/10.1016/j.clnu.2016.07.008.
40. Sugawara K., Takahashi H., Kasai C. et al. Effects of nutritional supplementation combined with low-intensity exercise in malnourished patients with COPD. Respir Med. 2010; 104(12): 1883–89. https://dx.doi.org/10.1016/j.rmed.2010.05.008.
41. Keogh E., Mark Williams E. Managing malnutrition in COPD: A review. Respir Med. 2021; 176: 106248. https://dx.doi.org/10.1016/j.rmed.2020.106248.
42. Ahnfeldt-Mollerup P., Hey H., Johansen C. et al. The effect of protein supplementation on quality of life, physical function, and muscle strength in patients with chronic obstructive pulmonary disease. Eur J Phys Rehabil Med. 2015; 51(4): 447–56.
43. van de Bool C., Rutten E.P.A., van Helvoort A. et al. A randomized clinical trial investigating the efficacy of targeted nutrition as adjunct to exercise training in COPD. J Cachexia Sarcopenia Muscle. 2017; 8(5): 748–58. https://dx.doi.org/10.1002/jcsm.12219.
Об авторах / Для корреспонденции
Дмитрий Юрьевич Костенко, к.м.н., ассистент кафедры факультетской и поликлинической терапии с курсом эндокринологии ФГБОУ ВО «Дальневосточный государственный медицинский университет» Минздрава России. Адрес: 680000, г. Хабаровск, ул. Карла Маркса, д. 35. E-mail: mitiacostencko@yandex.ru.ORCID: https://orcid.org/0000-0001-7057-8105
Также по теме
